Research unit
Project number
62192.1 IP-LS
Project title
Glycopeptides to drive an anti-tumour immune response and improve outcomes in cancer immunotherapies (Innolink: 101.651 IP-LS)
Project status In Process
Start date 15.09.2022
End date 15.09.2024
Granted total costs 678'170.00  CHF
Section 60 Life Sciences
Project category Project
Research type Applied research and development
NABS classification Industrial production and technology
Research disciplines
100 % T410 Pharmaceuticals and related technologies

Last modification of the project